Douglas Esser Email & Phone Number

o I inaugurated an innovative analytical solution to problem of duplicate discounts on 340B discounted prescriptions filled at contract pharmacies.o My team identified solution, performed pilot studies, statistical analyses, and business impact assessmentso Persuaded Managed Markets, Finance, and Legal senior management to adopt solution. o My team provided critical support in design, testing, and documentation during implementation of processo Used Machine Learning via R (H20) to automate process that identifies ineligible pharmacieso Led team that introduced Robotic Processing Automation to Financial Planning Analysis departmento Led team that developed and deployed five ‘bots using UIPath software which freed up weeks annually of FTE with less QC risk.

Upper Gwtnedd, Pa

o Created Contract Operation Analytics team which applies advanced analytical techniques using software such as R, and Python to generate business insights for managed care questions.o Supported Integrated Accounts Management, the managed care contracting organization within Merck, in evaluating contracting strategy, and optimizing pricing across whole portfolio (retail, Medicare Part B, injectable oncology drugs, etc.)

Upper Gwynedd, Pa

o I led development of U.S. healthcare provider (“HCP”) marketing and promotion strategy for Belsomra®, the only Orexin Receptor Antagonist for insomnia, including the pre-launch scientific awareness, and medical education campaigns.o I represented Belsomra® at the USHH Management Committee to secure support and funding for major marketing decisions, such as for pursuing orexin awareness campaign.o I developed both pre-launch scientific awareness campaign and branded launch U.S. HCP messaging and promotional strategy including construction of promotional materials.o I developed Medical Education strategy including channel selection, targeting, and design of speaker materials, and detail piece content.

Upper Gwynedd, Pa

o I directed commercial assessment and strategy development of sleep-wake disorder compounds in pre-clinical, Phase I and Phase II.o I represented marketing in Merck Research Labs drug development stage gate committee meetings o I developed scientific leader advisory boards to identify and understand insomnia commercial needs, and translated these needs into target product profiles, and study data requirements.o I performed market sizing, sales forecasting, licensing, and business development deal evaluation.

Uper Gwynedd, Pa

o I was responsible for commercial assessment and strategy development of compounds in pre-clinical, Phase I and Phase II. Therapeutic areas of focus included, inter alia: sleep-wake disorders, hypertension, metabolic disorders and infectious disease.

Uper Gwynedd, Pa

o I introduced advanced analytical techniques such as Bayesian inference to drive business insights across the pharmaceutical portfolio. o Managed six-member team with broad responsibilities including development of promotion response, and resource allocation models.o I developed direct to consumer (“DTC”) promotion portfolio optimization model which optimized television advertising spend of over $500MM across four brands.

o Sold Zocor®, Singulair®, Vioxx®, launched Singulair AR®, and Zetia®.o 2002 Vice President's Award Winner for outstanding sales performance.

Upper Gwynedd, Pa

Georgetown, Dc

Master Of Business Administration (M.B.A.), Finance, General

Master Of Science (Ms), Operations Research (Stochastic Processes)

Bachelor Of Arts (B.A.), Applied Mathematics